Latest Private Placement News

Resouro Strategic Metals is set to raise up to C$2 million through a non-brokered private placement to fund pre-feasibility studies and metallurgical work at its flagship Tiros project in Brazil, building on a recent robust preliminary economic assessment.

Australian Unity has secured $200 million through a private placement of wholesale debt, using part of the proceeds to buy back $51.5 million of its Series D Bonds ahead of their December 2026 maturity.

Resouro Strategic Metals has unveiled a robust Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project, signalling a post-tax NPV of US$715 million and a 44.2% IRR over 20 years. Meanwhile, binding agreements for mining and processing at the Novo Mundo Gold Project promise to unlock additional value.

HITIQ Limited has secured $1.4 million through a private placement of 200 million shares at 0.7 cents each, accompanied by options exercisable until 2029. The capital will bolster its balance sheet and back expansion and commercialisation efforts.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

EPX Limited has locked in a $3 million senior secured revolving loan note facility with Partners for Growth, providing capital to seize new revenue opportunities and support working capital over the next three years.

Patagonia Lithium has locked in A$3.4 million through a placement priced at 10 cents per share, attaching options exercisable at 16 cents. The capital injection aims to fund further drilling, resource upgrades, and a lithium carbonate demonstration plant at its flagship Formentera project.

Discovery Alaska has reported exceptional high-grade gold and silver results from rock samples at its Boulder Creek Project in Idaho, setting the stage for imminent drilling to test historic anomalous zones.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.

Dotz Nano has pushed out the maturity dates on its convertible notes to March 2027, securing continued backing from Mercer Street Capital. The move introduces new conversion limits and an option for cash settlements, signalling confidence in Dotz’s carbon capture ambitions.

Spenda Limited (ASX: SPX) has voluntarily suspended trading of its shares from 2 June 2026 to manage disclosure around its institutional accelerated renounceable entitlement offer (AREO). The suspension is expected to last until 10 June or until the AREO results are announced.